What is the TOUCH Prescribing Program?
The TOUCH Prescribing Program makes your safety a priority. TOUCH monitors every patient who has been prescribed TYSABRI treatment. The goal of the program is to minimize the risk of PML. • Because of the risk of PML, TYSABRI is available only through the TOUCH Prescribing Program, which is a restricted distribution program focused on safety • TOUCH was developed with the help of the Food and Drug Administration (FDA) • Only prescribers and patients enrolled in the TOUCH Prescribing Program can prescribe and receive TYSABRI • Only certain pharmacies and infusion sites authorized by the TOUCH Prescribing Program can dispense and infuse TYSABRI • TOUCH assigns you your own specially trained Case Manager to help: • Get you started on therapy and answer questions about your therapy • Find an authorized infusion site in your area • Provide information about insurance coverage and possible sources of financial assistance, if necessary • TOUCH offers more interaction with doctors and nurses.
Related Questions
- If I am receiving payments under the CMS Electronic Prescribing (eRx) Incentive Program, can I also receive Medicare and Medicaid Electronic Health Record (EHR) incentive payments?
- Can students touch (ie.. to set a different program) after it jumps the edge to run the line follower program and again before resetting arm and running that program?
- Does a reduction in antibiotic consumption always represent a favorable outcome from an intervention program on prescribing practice?
